Ionis Pharmaceuticals (IONS)
(Delayed Data from NSDQ)
$37.91 USD
+0.10 (0.26%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $37.93 +0.02 (0.05%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 35% (89 out of 252)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.86 | 1.55 | 9.99 |
Current Quarter Estimate | -1.16 | 0.44 | 63.00 |
Year Ago Quarter Estimate | -1.03 | 0.11 | 52.25 |
Next Quarter Estimate | -1.10 | -1.66 | 66.00 |
Next Year Estimate | -3.59 | 13.59 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -43.75 | 19.40 | 15.67 |
Next Year | 2.45 | 16.50 | 11.34 |
Last 5 Years | -207.80 | 7.80 | 8.10 |
Next 5 Years | 8.40 | 21.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.64 |
Price/Book (MRQ) | 21.02 | 1.51 |
Price/Cash Flow (MRFY) | NA | 8.65 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -44.90% | -56.43% |
Return on Equity (TTM) | -115.66% | -58.58% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.